Transasia Diagnostics Solutions Limited, a active public limited company, was established on 10 April 2019 in Mumbai, Maharashtra, India. Engaging in medical & laboratory equipment within the healthcare sector, it holds CIN: U33209MH2019PLC323939. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹0.50 M.
Its leadership includes Sunil Hassanand Vazirani (Director), Suresh Hassanand Vazirani (Director), Mala Suresh Vazirani (Director). Past directors included Sunil Hassanand Vazirani, Vibhuti Suresh Vazirani, Francis Perikalm Matthew. Its latest AGM occurred on 10 September 2024, with the balance sheet filed on 31 March 2024. It is based at Transasia House, 8, Chandivali Studio Rd Andheri (East), Mumbai, Maharashtra, 400072.
U33209MH2019PLC323939
323939
10 April 2019
₹1.50 M
₹0.50 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Transasia Diagnostics Solutions Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sunil Hassanand Vazirani | Director | 01 Apr 2024 | Current |
| Suresh Hassanand Vazirani | Director | 10 Apr 2019 | Current |
| Mala Suresh Vazirani | Director | 10 Apr 2019 | Current |
| Vibhuti Suresh Vazirani | Director | 09 Mar 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 09 Sep 2024 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2022 | Past |
| Pramod Abcsdd | Director | 10 Feb 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Transasia Diagnostics Solutions Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 99.01% decrease. The company also saw a substantial fall in profitability, with a 365.47% decrease in profit. The company's net worth observed a substantial decline by a decrease of 113.64%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Transasia Diagnostics Solutions had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Transasia Diagnostics Solutions, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Transasia Diagnostics Solutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Transasia Diagnostics Solutions's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Transasia Diagnostics Solutions Limited last Annual general meeting of members was held on 10 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Sunil Hassanand Vazirani was appointed as a Director was appointed as a Director on 01 Apr 2024 & has been associated with this company since 1 year 7 months . was completed.
Transasia Diagnostics Solutions Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
Progress on Vibhuti Suresh Vazirani was appointed as a Director was appointed as a Director on 09 Mar 2022 & has been associated with this company since 3 years 8 months . was documented.
Progress on Suresh Hassanand Vazirani was appointed as a Director was appointed as a Director on 10 Apr 2019 & has been associated with this company since 6 years 7 months . was documented.
Progress on Mala Suresh Vazirani was appointed as a Director was appointed as a Director on 10 Apr 2019 & has been associated with this company since 6 years 7 months . was documented.
Transasia Bio-Medicals Ltd., India’s leading In-vitro Diagnostic Company, unveiled ‘SAVIOUR’, a location based blood donation app that is available free to everyone. It is the first in India to be on.
The CIN of Transasia Diagnostics Solutions Limited is U33209MH2019PLC323939.
Transasia Diagnostics Solutions Limited is headquartered at Transasia House, 8, Chandivali Studio Rd Andheri (East), Mumbai, Maharashtra, 400072.
Transasia Diagnostics Solutions Limited was incorporated on 10 April 2019.
The current directors of Transasia Diagnostics Solutions Limited are
The primary industry of Transasia Diagnostics Solutions Limited is Healthcare.
Transasia Diagnostics Solutions Limited is unlisted.
The authorized capital of Transasia Diagnostics Solutions Limited is ₹1.50 M, and the paid-up capital is ₹0.50 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX